Altimmune, Inc.

Altimmune, Inc.

Biotechnology • Healthcare • Gaithersburg, MD, United States • ALT (NGM)

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

240 654 1450 910 Clopper Road, Gaithersburg, MD 20878, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Altimmune Amends Loan Agreement with Hercules Capital - MSN
MSN • Dec 12
Altimmune stock tumbles after MASH drug trial data - Investing.com
Investing.com • Dec 19
$ALT stock is down 4% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitative • Dec 26
Insider Buying: Altimmune Independent Chairman Bought US$52k Of Shares - simplywall.st
simplywall.st • Dec 28
Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets - ts2.tech
ts2.tech • Dec 17

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Altimmune, Inc. had layoffs?
No layoff events have been recorded for Altimmune, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Altimmune, Inc. have?
Altimmune, Inc. has approximately 59 employees.
What industry is Altimmune, Inc. in?
Altimmune, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Altimmune, Inc. a publicly traded company?
Yes, Altimmune, Inc. is publicly traded under the ticker symbol ALT on the NGM. The company has a market capitalization of approximately $0.40 billion.
Where is Altimmune, Inc. headquartered?
Altimmune, Inc. is headquartered in Gaithersburg, MD, United States at 910 Clopper Road, Gaithersburg, MD 20878, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.